Protagonist Therapeutics PTGX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $128.39M+32.0% | $97.25M-47.9% | $186.73M+48.5% | $125.74M+1.7% | ||
| $438.97M+36.5% | $321.66M+108% | $154.89M+38.8% | $111.61M-45.1% | ||
| $577.57M-2.4% | $591.64M+66.4% | $355.58M+46.3% | $243.08M-28.7% | ||
| $3.86M+21.0% | $3.19M+167% | $1.2M-23.6% | $1.57M-13.0% | ||
| $668.19M-10.3% | $744.73M+108% | $357.95M+44.4% | $247.93M-28.7% | ||
| $9.55M-18.2% | $11.68M+389,100% | $3K-95.7% | $69K-92.3% | ||
| $45.44M-4.1% | $47.4M+123% | $21.27M-31.8% | $31.18M-29.2% | ||
| $53.48M-23.0% | $69.43M+226% | $21.27M-34.2% | $32.32M-32.2% | ||
| $1K0.0% | $1K0.0% | $1K— | —— | ||
| -$470.67M-38.2% | -$340.52M+44.7% | -$615.71M-14.7% | -$536.76M-31.1% | ||
| $614.71M-9.0% | $675.3M+101% | $336.68M+56.2% | $215.61M-28.1% | ||
| $668.19M-10.3% | $744.73M+108% | $357.95M+44.4% | $247.93M-28.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Protagonist Therapeutics's total assets?
- Protagonist Therapeutics (PTGX) holds $697.5M in total assets, down 6.0% year over year.
- How much debt does Protagonist Therapeutics have?
- Protagonist Therapeutics carries $9.8M in total debt against $655.5M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Protagonist Therapeutics have?
- Protagonist Therapeutics holds $193.7M in cash and equivalents.
- Can Protagonist Therapeutics cover its short-term obligations?
- Its current ratio is 17.76 — current assets exceed current liabilities.
- Where does Protagonist Therapeutics's balance sheet data come from?
- Every line is extracted from Protagonist Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
